Heartland Advisors Inc. Trims Stock Position in InfuSystem Holdings, Inc. (NYSEAMERICAN:INFU)

Heartland Advisors Inc. trimmed its holdings in shares of InfuSystem Holdings, Inc. (NYSEAMERICAN:INFU) by 9.1% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 454,728 shares of the medical instruments supplier’s stock after selling 45,272 shares during the period. Heartland Advisors Inc. owned about 2.15% of InfuSystem worth $4,793,000 as of its most recent SEC filing.

Several other institutional investors have also recently modified their holdings of the stock. First Eagle Investment Management LLC grew its holdings in shares of InfuSystem by 29.6% during the third quarter. First Eagle Investment Management LLC now owns 468,400 shares of the medical instruments supplier’s stock worth $4,515,000 after buying an additional 107,001 shares in the last quarter. Citigroup Inc. boosted its position in InfuSystem by 124.1% during the third quarter. Citigroup Inc. now owns 50,640 shares of the medical instruments supplier’s stock worth $488,000 after acquiring an additional 28,038 shares during the last quarter. Finally, WINTON GROUP Ltd purchased a new stake in InfuSystem in the 3rd quarter worth approximately $101,000. 71.13% of the stock is currently owned by institutional investors and hedge funds.

InfuSystem Trading Up 2.7 %

Shares of NYSEAMERICAN INFU traded up $0.17 during trading on Friday, reaching $6.51. 19,758 shares of the stock were exchanged, compared to its average volume of 43,253. The stock has a market cap of $138.66 million, a P/E ratio of -634,000.00 and a beta of 1.30. The company has a current ratio of 1.87, a quick ratio of 1.51 and a debt-to-equity ratio of 0.57. InfuSystem Holdings, Inc. has a twelve month low of $6.25 and a twelve month high of $11.44.

Wall Street Analyst Weigh In

A number of research firms have recently commented on INFU. StockNews.com downgraded shares of InfuSystem from a “strong-buy” rating to a “buy” rating in a research note on Monday. Lake Street Capital raised shares of InfuSystem to a “strong-buy” rating in a research report on Thursday, May 9th.

About InfuSystem

InfuSystem Holdings, Inc, through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states.